LHX vs ORMP
L3Harris Technologies Inc (LHX) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LHX revenue for 2025-01-03 was $21.32B. Net income was $1.51B. Revenue was up 9.8% from 2023-12-29 to 2025-01-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LHX and ORMP stock pages for the full models.
Not investment advice.